The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection

被引:1485
作者
Gardner, Edward M. [1 ,3 ]
McLees, Margaret P. [1 ,3 ]
Steiner, John F. [2 ]
del Rio, Carlos [4 ,5 ]
Burman, William J. [1 ,3 ]
机构
[1] Denver Publ Hlth, Denver, CO 80204 USA
[2] Kaiser Permanente Colorado, Denver, CO USA
[3] Univ Colorado Denver, Aurora, CO USA
[4] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[5] Emory Ctr AIDS Res, Atlanta, GA USA
关键词
ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; MEDICAL-CARE; UNITED-STATES; FOLLOW-UP; SEXUAL TRANSMISSION; DELAYED INITIATION; SOUTH-CAROLINA; LATE DIAGNOSIS; PERSONS AWARE;
D O I
10.1093/cid/ciq243
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
For individuals with human immunodeficiency virus (HIV) infection to fully benefit from potent combination antiretroviral therapy, they need to know that they are HIV infected, be engaged in regular HIV care, and receive and adhere to effective antiretroviral therapy. Test-and-treat strategies for HIV prevention posit that expanded testing and earlier treatment of HIV infection could markedly decrease ongoing HIV transmission, stemming the HIV epidemic. However, poor engagement in care for HIV-infected individuals will substantially limit the effectiveness of test-and-treat strategies. We review the spectrum of engagement in care for HIV-infected individuals in the United States and apply this information to help understand the magnitude of the challenges that poor engagement in care will pose to test-and-treat strategies for HIV prevention.
引用
收藏
页码:793 / 800
页数:8
相关论文
共 83 条
[1]   Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the women's interagency HIV study [J].
Ahdieh-Grant, L ;
Tarwater, PM ;
Schneider, ME ;
Anastos, K ;
Cohen, M ;
Khalsa, A ;
Minkoff, H ;
Young, M ;
Greenblatt, RM .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (04) :500-503
[2]  
[Anonymous], 2006, MMWR MORB MORTAL WKL
[3]  
[Anonymous], 2009, Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, P1
[4]  
[Anonymous], MMWR MORB MORTAL WKL
[5]  
[Anonymous], 12 C RETR OPP INF BO
[6]  
Arici Claudio, 2002, HIV Clin Trials, V3, P52
[7]   Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis [J].
Attia, Suzanna ;
Egger, Matthias ;
Mueller, Monika ;
Zwahlen, Marcel ;
Low, Nicola .
AIDS, 2009, 23 (11) :1397-1404
[8]   Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression [J].
Bangsberg, David R. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :939-941
[9]   Changes in the risk of death after HIV seroconversion compared with mortality in the general population [J].
Bhaskaran, Krishnan ;
Hamouda, Osamah ;
Sannes, Mette ;
Boufassa, Faroudy ;
Johnson, Anne M. ;
Lambert, Paul C. ;
Porter, Kholoud .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (01) :51-59
[10]   A tale of two futures: HIV and antiretroviral therapy in San Francisco [J].
Blower, SM ;
Gershengorn, HB ;
Grant, RM .
SCIENCE, 2000, 287 (5453) :650-654